Green Thumb Industries (OTCMKTS:GTBIF - Get Free Report) was upgraded by investment analysts at Roth Capital to a "strong-buy" rating in a note issued to investors on Sunday,Zacks.com reports.
Other equities analysts also recently issued research reports about the stock. Ventum Cap Mkts raised shares of Green Thumb Industries to a "strong-buy" rating in a research note on Tuesday, August 6th. Craig Hallum upgraded Green Thumb Industries to a "strong-buy" rating in a research note on Monday, September 16th. Three equities research analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Strong Buy" and a consensus price target of $16.50.
Read Our Latest Report on GTBIF
Green Thumb Industries Price Performance
Shares of OTCMKTS:GTBIF traded up $1.15 during trading on Friday, hitting $8.95. 893,041 shares of the company's stock were exchanged, compared to its average volume of 464,708. The business's 50-day simple moving average is $10.26 and its 200 day simple moving average is $11.14. Green Thumb Industries has a 52-week low of $7.50 and a 52-week high of $16.33. The company has a market cap of $1.89 billion, a price-to-earnings ratio of 33.15 and a beta of 1.40.
Green Thumb Industries (OTCMKTS:GTBIF - Get Free Report) last posted its earnings results on Thursday, November 7th. The company reported $0.04 EPS for the quarter, missing analysts' consensus estimates of $0.06 by ($0.02). Green Thumb Industries had a net margin of 5.38% and a return on equity of 3.39%. The business had revenue of $286.87 million for the quarter, compared to analyst estimates of $283.96 million. On average, sell-side analysts anticipate that Green Thumb Industries will post 0.32 EPS for the current fiscal year.
About Green Thumb Industries
(
Get Free Report)
Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.
Further Reading
Before you consider Green Thumb Industries, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Green Thumb Industries wasn't on the list.
While Green Thumb Industries currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
